| 1 |
33661628 | Oligomannose N-Glycans 3D Architecture and Its Response to the FcγRIIIa Structural Landscape. | 2021 Mar 18 |
1 |
| 2 |
31888963 | Site-specific N-glycan Analysis of Antibody-binding Fc γ Receptors from Primary Human Monocytes. | 2020 Feb |
8 |
| 3 |
32222585 | Glycosylation of Fcγ receptors influences their interaction with various IgG1 glycoforms. | 2020 May |
3 |
| 4 |
32390308 | Highly sensitive HPLC analysis and biophysical characterization of N-glycans of IgG-Fc domain in comparison between CHO and 293 cells using FcγRIIIa ligand. | 2020 Nov |
2 |
| 5 |
32812835 | Assessment of the role of afucosylated glycoforms on the in vitro antibody-dependent phagocytosis activity of an antibody to Aβ aggregates. | 2020 Jan-Dec |
1 |
| 6 |
30466347 | Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms. | 2019 Feb/Mar |
1 |
| 7 |
29330305 | Restricted processing of CD16a/Fc γ receptor IIIa N-glycans from primary human NK cells impacts structure and function. | 2018 Mar 9 |
4 |
| 8 |
30213862 | CD16a with oligomannose-type N-glycans is the only "low-affinity" Fc γ receptor that binds the IgG crystallizable fragment with high affinity in vitro. | 2018 Oct 26 |
2 |
| 9 |
30361439 | A single amino acid distorts the Fc γ receptor IIIb/CD16b structure upon binding immunoglobulin G1 and reduces affinity relative to CD16a. | 2018 Dec 21 |
1 |
| 10 |
28613884 | Carbohydrate-Polypeptide Contacts in the Antibody Receptor CD16A Identified through Solution NMR Spectroscopy. | 2017 Jun 27 |
5 |
| 11 |
26200113 | Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities. | 2015 |
2 |
| 12 |
26444434 | Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors. | 2015 |
2 |
| 13 |
22023369 | Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans. | 2011 Nov |
2 |
| 14 |
12145191 | N-glycosylation profile of recombinant human soluble Fcgamma receptor III. | 2002 Aug |
1 |